Department of General Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, PA, USA.
Am Surg. 2023 Nov;89(11):4373-4378. doi: 10.1177/00031348221111516. Epub 2022 Jun 27.
Bracketed localization is a technique used to help localize lesions for breast-conserving surgery (BCS). To date, there are no guidelines for when bracketed localization should be used in clinical practice. Based on our experience, we aim to provide criteria that should prompt surgeons to consider bracketing.
A single-institution retrospective chart review was performed on patients who underwent bracketed localization for BCS between 2015 and 2021. Lesion characteristics were recorded including lesion span, number of lesions, histology type on core needle biopsy and surgical specimen, margin status, and need for additional surgery.
One hundred and thirteen cases were analyzed. Imaging showed an average lesion span of 5.0-cm. Multifocal lesions represented 45% of cases. Ductal carcinoma in situ (DCIS) was a histological component in 64% of core needle biopsies and 76% of surgical specimens. Negative margins were achieved in 82% of patients on the first excision. Additional surgery was performed in 17% of patients. Invasive lobular carcinoma had the highest additional surgery rate at 23%. Negative margins with BCS were achieved in 96% of cases, including those with successful re-excision.
This descriptive study shows that bracketed localization was most often employed for patients with large lesion spans, multifocality, and a DCIS or invasive lobular component. While these characteristics are typically associated with higher rates of positive margins, our cohort's rate of additional surgery was comparable to the national average for all BCS operations. These results argue that surgeon utilization of bracketed localization may be beneficial in these clinical scenarios.
括号定位是一种用于帮助定位保乳手术(BCS)病变的技术。迄今为止,尚无关于在临床实践中何时应使用括号定位的指南。根据我们的经验,我们旨在提供应促使外科医生考虑使用括号定位的标准。
对 2015 年至 2021 年间接受括号定位行 BCS 的患者进行了单机构回顾性图表审查。记录了病变特征,包括病变跨度、病变数量、核心针活检和手术标本的组织学类型、切缘状态以及是否需要额外手术。
分析了 113 例病例。影像学显示平均病变跨度为 5.0cm。多灶性病变占 45%。核心针活检中有 64%和手术标本中有 76%为导管原位癌(DCIS)。首次切除时 82%的患者获得了阴性切缘。17%的患者进行了额外手术。浸润性小叶癌的额外手术率最高,为 23%。96%的患者(包括成功再次切除的患者)实现了 BCS 的阴性切缘。
这项描述性研究表明,括号定位最常用于病变跨度大、多灶性、DCIS 或浸润性小叶癌成分的患者。虽然这些特征通常与更高的阳性切缘率相关,但我们队列的额外手术率与所有 BCS 手术的全国平均水平相当。这些结果表明,外科医生使用括号定位可能在这些临床情况下是有益的。